In the tumor microenvironment, tumor-associated macrophages (TAMs) can inhibit the anti-tumor effector function of T cells and enhance the immune escape ability of tumor cells by hijacking the PD-1/PD-L1 signaling pathway. Here, PDCD1 is linked to neoplasm.